Accessibility: Skip TopNav
Figure 1
A single IV dose of ENTR-601-44 resulted in robust exon skipping in both skeletal and cardiac muscles in NHP, as well as prolonged duration of effect for at least 12 weeks
Format
JPEG
Quelle:
Entrada Therapeutics, Inc.
Downloads
Originalgröße
Groß
Mittel
Klein